Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1986 1
1990 1
1991 2
1995 1
2001 1
2003 1
2004 1
2005 1
2006 1
2007 2
2008 1
2010 4
2011 3
2012 5
2013 4
2014 6
2015 6
2016 5
2017 5
2018 4
2019 6
2020 8
2021 4
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
Acin F, de Haro J, Bleda S, Varela C, Esparza L. Acin F, et al. J Endovasc Ther. 2012 Oct;19(5):585-95. doi: 10.1583/JEVT-12-3898R.1. J Endovasc Ther. 2012. PMID: 23046322 Review.
PURPOSE: To determine the efficacy and safety of balloon angioplasty (BA) with optional stenting vs. routine stenting with current open cell nitinol stents for femoropopliteal occlusive disease by analyzing the overall results from all available randomized …
PURPOSE: To determine the efficacy and safety of balloon angioplasty (BA) with optional stenting vs. routine stenting with current open cell …
Primary stenting in femoropopliteal occlusive disease - what is the appropriate role?
Yiu WK, Conte MS. Yiu WK, et al. Circ J. 2015;79(4):704-11. doi: 10.1253/circj.CJ-15-0199. Epub 2015 Mar 13. Circ J. 2015. PMID: 25766515 Free article. Review.
Endovascular treatment of femoropopliteal occlusive disease is challenging and often limited by its unique anatomic, hemodynamic and biomechanical constraints. ...Although these technologies look promising, a uniform reporting system and large-scale comparati …
Endovascular treatment of femoropopliteal occlusive disease is challenging and often limited by its unique anatomic, he …
Advances in endovascular treatment of femoropopliteal arterial occlusive disease.
Klonaris C, Katsargyris A, Giannopoulos A, Bastounis E. Klonaris C, et al. Perspect Vasc Surg Endovasc Ther. 2006 Dec;18(4):329-41. doi: 10.1177/1531003506297953. Perspect Vasc Surg Endovasc Ther. 2006. PMID: 17351203 Review.
However, despite the established role of endoluminal approaches in many other arterial territories, their application for the treatment of femoropopliteal occlusive disease is still debatable due to unique unfavorable anatomical, functional, and flow characte …
However, despite the established role of endoluminal approaches in many other arterial territories, their application for the treatment of …
Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis.
Mwipatayi BP, Hockings A, Hofmann M, Garbowski M, Sieunarine K. Mwipatayi BP, et al. J Vasc Surg. 2008 Feb;47(2):461-9. doi: 10.1016/j.jvs.2007.07.059. Epub 2007 Oct 22. J Vasc Surg. 2008. PMID: 17950563 Free article. Review.
BACKGROUND: The goal of this study was to review the currently available literature and to compare the short and long-term results of primary stenting and angioplasty of femoropopliteal occlusive disease by performing a meta-analysis review. ...CONCLUSIONS: T …
BACKGROUND: The goal of this study was to review the currently available literature and to compare the short and long-term results of primar …
Drug-Eluting Balloon Therapy for Femoropopliteal Occlusive Disease: Predictors of Outcome With a Special Emphasis on Calcium.
Tepe G, Beschorner U, Ruether C, Fischer I, Pfaffinger P, Noory E, Zeller T. Tepe G, et al. J Endovasc Ther. 2015 Oct;22(5):727-33. doi: 10.1177/1526602815600156. Epub 2015 Aug 6. J Endovasc Ther. 2015. PMID: 26250747
One possible approach to overcome this limitation might be plaque modification or removal prior to DEB usage. Nevertheless, clinical data that support this hypothesis are currently lacking....
One possible approach to overcome this limitation might be plaque modification or removal prior to DEB usage. Nevertheless, clinical …
Optical coherence tomography guided directional atherectomy with antirestenotic therapy for femoropopliteal arterial disease.
Stavroulakis K, Bisdas T, Torsello G, Argyriou A, Bollenberg L, Schwindt A. Stavroulakis K, et al. J Cardiovasc Surg (Torino). 2019 Apr;60(2):191-197. doi: 10.23736/S0021-9509.19.10843-9. Epub 2019 Jan 18. J Cardiovasc Surg (Torino). 2019. PMID: 30665284
Aim of this study was to evaluate the performance of OCT-guided DAART in the treatment of femoropopliteal atherosclerosis. METHODS: Patients treated by OCT-guided DAART for femoropopliteal occlusive disease between January 2015 and December 2016 were included …
Aim of this study was to evaluate the performance of OCT-guided DAART in the treatment of femoropopliteal atherosclerosis. METHODS: Patients …
Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis.
Parikh SA, Schneider PA, Mullin CM, Rogers T, Gray WA. Parikh SA, et al. Lancet. 2023 Nov 18;402(10415):1848-1856. doi: 10.1016/S0140-6736(23)02189-X. Epub 2023 Oct 24. Lancet. 2023. PMID: 37890499
BACKGROUND: Numerous randomised clinical trials and real-world studies have supported the safety of paclitaxel-coated devices for the treatment of femoropopliteal occlusive disease. ...
BACKGROUND: Numerous randomised clinical trials and real-world studies have supported the safety of paclitaxel-coated devices …
How to interpret data from the superficial femoral artery stenting trials and registries.
Lin PH, Weakley SM, Kougias P. Lin PH, et al. Semin Vasc Surg. 2010 Sep;23(3):138-47. doi: 10.1053/j.semvascsurg.2010.05.001. Semin Vasc Surg. 2010. PMID: 20826290 Review.
Recent advances in endovascular technologies have made catheter-based interventions a preferred treatment strategy in patients with intermittent claudication or ischemic rest pain of the lower extremity. Although the current body of literature is inundated with clinical re …
Recent advances in endovascular technologies have made catheter-based interventions a preferred treatment strategy in patients with intermit …
Long-term clinical outcomes after self-expandable bare nitinol stent implantation for femoropopliteal occlusive disease in hemodialysis patients.
Ito R, Ishii H, Oshima S, Nakayama T, Takahashi H, Sakakibara T, Kakuno M, Murohara T. Ito R, et al. Catheter Cardiovasc Interv. 2021 Feb 1;97(2):318-324. doi: 10.1002/ccd.29372. Epub 2020 Nov 12. Catheter Cardiovasc Interv. 2021. PMID: 33179857
OBJECTIVES: To compare the long-term clinical outcomes after self-expandable bare nitinol stent (BNS) implantation between hemodialysis (HD) and non-HD patients with femoropopliteal (FP) disease. ...
OBJECTIVES: To compare the long-term clinical outcomes after self-expandable bare nitinol stent (BNS) implantation between hemodialys …
One-Year Clinical Outcome and Risk Factor Analysis of Directional Atherectomy Followed With Drug-Coated Balloon for Femoropopliteal Artery Disease.
Feng Z, Yang S, Sang H, Xue G, Ni Q, Zhang L, Zhang W, Fang X, Ye M. Feng Z, et al. J Endovasc Ther. 2021 Dec;28(6):927-937. doi: 10.1177/15266028211030527. Epub 2021 Jul 12. J Endovasc Ther. 2021. PMID: 34251279
PURPOSE: This study investigated the 1-year clinical outcomes of directional atherectomy combined with drug-coated balloon (DA + DCB) in femoropopliteal artery disease (FPAD) from real-world experience. ...CONCLUSION: DA + DCB appears to be a safe and effective endovascula …
PURPOSE: This study investigated the 1-year clinical outcomes of directional atherectomy combined with drug-coated balloon (DA + DCB) …
63 results